This report contains market size and forecasts of Ruxolitinib in global, including the following market information:
Global Ruxolitinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ruxolitinib Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Ruxolitinib companies in 2021 (%)
The global Ruxolitinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ruxolitinib include Novartis, Shandong Chuangxin Pharmaceutical Research and Development, Orifarm AS and Incyte Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ruxolitinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ruxolitinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ruxolitinib Market Segment Percentages, by Type, 2021 (%)
5mg Tablets
10mg Tablets
15mg Tablets
20mg Tablets
Global Ruxolitinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ruxolitinib Market Segment Percentages, by Application, 2021 (%)
Moderate Myelofibrosis
High Risk Myelofibrosis
Polycythemia Vera
Other
Global Ruxolitinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Ruxolitinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ruxolitinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ruxolitinib revenues share in global market, 2021 (%)
Key companies Ruxolitinib sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Ruxolitinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Shandong Chuangxin Pharmaceutical Research and Development
Orifarm AS
Incyte Corporation